Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Additional patent coverage for Maxim anticancer combination

Sep. 6, 1996

AltaRex and Medac finalize Ovarex partnership

Aug. 30, 1996

Imutec/NaPro BioTherapeutics sign research agreement

Aug. 23, 1996

C242-DM1: Promising new approach to colorectal cancer treatment

Aug. 23, 1996

MDX-210 efficacy/safety trial begins in U.K.

Aug. 23, 1996

Progenic's GMK undergoes phase III clinical trials

Aug. 23, 1996

AltaRex awaits Canadian approval to begin Ovarex phase II/III trials

Aug. 23, 1996

European approval sought for new Rebif indications

Aug. 23, 1996

U.S. patent will issue covering GLIOMAB-H

Aug. 16, 1996

BEC2, ImClone Systems' therapeutic vaccine protected under U.S. patent

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...